ClinicalTrials.Veeva

Menu

Infective Endocarditis After TAVR (INTENSE)

R

Region Skane

Status

Completed

Conditions

Infective Endocarditis of Aortic Valve

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims at studying the frequency of infective endocarditis after transcatheter aortic valve replacement/implantation

Full description

Since the start of transcatheter aortic valve implnatations/replacements (TAVR/TAVI) implantations in Sweden in 2008 all procedures have been added to a national database, which now contains 4500+ procedures. At the same time, all admissions to the hospital is also recorded with diagnosis in a separate database. We intend to make a nation-wide complete follow up of all TAVR/TAVI patients in swede that has received the diagnosis of infective endocarditis after the implantation. In addition data will also be collected from the national endocarditis database for detailed information of the cases.

Enrollment

4,600 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients that has under TAVR/TAVI in Sweden between 2008 and 2018

Exclusion criteria

Patients unable to follow up due to emigration or missing social security number

Trial design

4,600 participants in 1 patient group

Patient with infective endocarditis
Description:
All patients diagnosed with infective endocarditis after TAVR

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems